- Zacks•17 days ago
GlaxoSmithKline plc (GSK)'s fourth quarter beat estimates but the outlook for 2017 was weak amid a potential entry of generics for Advair.
- Zacks•23 days ago
AstraZeneca PLC (AZN) reported fourth-quarter 2016 core earnings of $1.21 per American Depositary Share, which comfortably beat the Zacks Consensus Estimate of 51 cents. Core earnings also rose 9% year over year.
- Zacks•last month
Pfizer Inc. (PFE) announced positive top-line results from a phase II study on its investigational vaccine candidate, PF-06425090, for the prevention of clostridium difficile infection.
ENZ : Summary for Enzo Biochem, Inc. ($0.01 Par - Yahoo Finance
Enzo Biochem, Inc. (ENZ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||6.51 - 6.67|
|52 Week Range||4.00 - 7.51|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||7.92|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|